SBRT combined with PD-1 inhibitors and thoracic hyperthermia
SBRT-PT
Phase 2 other active
Quick answer
SBRT combined with PD-1 inhibitors and thoracic hyperthermia for Stereotactic Body Radiation Therapy; PD-1 Inhibitor; Hyperthermia; NSCLC is a Phase 2 program (other) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- First Tracks Biotherapeutics
- Indication
- Stereotactic Body Radiation Therapy; PD-1 Inhibitor; Hyperthermia; NSCLC
- Phase
- Phase 2
- Modality
- other
- Status
- active